KalVista Pharmaceuticals ... (KALV)
KalVista Pharmaceuticals Max Pain By Strike
KALV trades at $14.01, 12.1% above the near-term max pain of $12.5 expiring Sep 19, 2025 (6 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($10-$55), signaling increased put positioning or downside protection. Key magnetic zone at 13 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
KalVista Pharmaceuticals Max Pain By Expiry
Max pain for KALV shows a downward trend from 55 to 10, indicating bearish sentiment or hedging activity. The 214% spread signals divergent expectations across timeframes. Levels distributed around 14.01. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 12.5 | -1.51 (-10.78%) |
| Oct 17, 2025 | 15 | 0.99 (7.07%) |
| Dec 19, 2025 | 10 | -4.01 (-28.62%) |
| Jan 16, 2026 | 55 | 40.99 (292.58%) |
| Mar 20, 2026 | 12.5 | -1.51 (-10.78%) |